General Information of the Compound
Compound ID
CP0412405
Compound Name
4-heptyl-N-pyridin-3-ylbenzamide
    Show/Hide
Synonyms
4-heptyl-N-(pyridin-3-yl)benzamide
CHEMBL263921
    Show/Hide
Structure
Formula
C19H24N2O
Molecular Weight
296.414
Canonical SMILES
CCCCCCCc1ccc(cc1)C(=O)Nc1cccnc1
    Show/Hide
InChI
InChI=1S/C19H24N2O/c1-2-3-4-5-6-8-16-10-12-17(13-11-16)19(22)21-18-9-7-14-20-15-18/h7,9-15H,2-6,8H2,1H3,(H,21,22)
    Show/Hide
InChIKey
XRYFRVDOZOSYGN-UHFFFAOYSA-N
Physicochemical Property
logP
4.8468
Rotatable Bonds
8
Heavy Atom Count
22
Polar Areas
41.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44450346
ChEMBL ID
CHEMBL263921
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
EC50 = 3700 nM
   TI
   LI
   LO
   TS
2
Ki = 1740 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-heptyl-N-(pyridin-3-yl)benzamide )
Drug Name 4-heptyl-N-(pyridin-3-yl)benzamide
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Inhibitor